Health Care & Life Sciences » Pharmaceuticals | Shandong Jincheng Pharmaceutical Co. Ltd.

Shandong Jincheng Pharmaceutical Co. Ltd. A | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
64,596.70
108,700.70
169,204.90
156,247.90
290,254.80
282,523.80
Depreciation, Depletion & Amortization
56,786.30
71,343.50
83,334.00
89,523.60
154,035.30
175,030.20
Other Funds
36,720.40
65,819.20
25,399.10
32,306.00
293,610.70
183,796.70
Funds from Operations
147,383.80
188,199.40
263,448.00
249,402.90
451,941.00
629,946.90
Changes in Working Capital
53,461.80
13,190.60
71,320.20
20,360.40
311,963.60
276,721.50
Net Operating Cash Flow
93,922.00
201,390.00
192,127.80
229,042.50
139,977.40
353,225.40
Capital Expenditures
160,178.20
159,566.30
159,852.10
158,893.30
177,554.30
Sale of Fixed Assets & Businesses
193.70
1,173.70
928.60
45,862.00
35,795.00
Purchase/Sale of Investments
4,800.00
-
2,500.00
50,000.00
3,824.40
Net Investing Cash Flow
160,550.70
195,200.40
145,436.10
162,583.90
147,969.70
Cash Dividends Paid - Total
-
24,200.00
37,892.40
37,980.00
58,972.80
Issuance/Reduction of Debt, Net
15,700.00
8,070.00
17,670.00
14,860.00
-
Net Financing Cash Flow
21,020.40
33,549.20
30,163.30
25,534.00
245,097.90
Net Change in Cash
87,649.10
39,738.80
16,528.40
40,924.60
237,035.00
Free Cash Flow
66,256.20
41,823.80
32,275.70
70,149.20
37,577.00
Deferred Taxes & Investment Tax Credit
1,056.40
1,981.20
12,210.50
2,266.70
7,240.70
11,403.90
Net Assets from Acquisitions
-
47,307.90
-
10,903.60
12,386.00
Other Sources
4,233.80
10,500.00
15,987.30
11,351.00
10,000.00
Change in Capital Stock
-
-
-
5,000.00
-
Exchange Rate Effect
-
-
-
-
70.60

About Shandong Jincheng Pharmaceutical Co.

View Profile
Address
Zichuan Economic Development Zone
Zibo Shandong 255100
China
Employees -
Website http://www.jinchengpharm.com
Updated 07/08/2019
Shandong Jincheng Pharmaceutical Group Co., Ltd. engages in the research and development, production and sale of III and IV cephalosporin intermediates and bio-pharmaceuticals. Its products are categorized into the following divisions: Characteristic Bulk Drugs, Pharmaceutical Intermediates, and Fine Chemicals. The company was founded by Hong Fu Zhao on January 12, 2004 and is headquartered in Zibo, China.